Your browser is no longer supported. Please, upgrade your browser.
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E37.04 EPS (ttm)3.21 Insider Own0.70% Shs Outstand1.78B Perf Week-0.49%
Market Cap211.05B Forward P/E21.97 EPS next Y5.41 Insider Trans-3.15% Shs Float1.76B Perf Month-1.62%
Income5.75B PEG2.27 EPS next Q1.23 Inst Own75.80% Short Float0.83% Perf Quarter-4.47%
Sales37.34B P/S5.65 EPS this Y24.50% Inst Trans-0.05% Short Ratio2.91 Perf Half Y4.77%
Book/sh18.89 P/B6.30 EPS next Y7.36% ROA8.10% Target Price135.84 Perf Year26.94%
Cash/sh4.72 P/C25.21 EPS next 5Y16.32% ROE17.80% 52W Range86.16 - 128.54 Perf YTD8.63%
Dividend1.80 P/FCF43.19 EPS past 5Y7.80% ROI9.70% 52W High-7.47% Beta0.68
Dividend %1.51% Quick Ratio1.30 Sales past 5Y11.10% Gross Margin56.90% 52W Low38.05% ATR1.93
Employees109000 Current Ratio1.80 Sales Q/Q35.30% Oper. Margin18.10% RSI (14)43.90 Volatility1.63% 1.58%
OptionableYes Debt/Eq0.55 EPS Q/Q227.60% Profit Margin15.30% Rel Volume0.78 Prev Close118.95
ShortableYes LT Debt/Eq0.52 EarningsApr 20 BMO Payout47.50% Avg Volume5.02M Price118.94
Recom1.80 SMA20-2.02% SMA50-0.92% SMA2006.21% Volume3,897,290 Change-0.01%
Apr-15-21Initiated Atlantic Equities Neutral $122
Jan-28-21Upgrade BTIG Research Neutral → Buy $140
Sep-11-20Initiated Wolfe Research Outperform $124
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
May-07-21 01:20PM  
10:21AM  
May-06-21 09:00AM  
07:01AM  
May-05-21 05:50PM  
01:13AM  
May-04-21 01:05PM  
07:01AM  
06:48AM  
Apr-28-21 11:54AM  
Apr-26-21 04:39PM  
Apr-22-21 07:13AM  
07:01AM  
06:00AM  
Apr-21-21 09:35AM  
08:49AM  
06:09AM  
Apr-20-21 05:07PM  
04:12PM  
02:30PM  
11:22AM  
10:04AM  
09:49AM  
08:55AM  
08:02AM  
07:57AM  
07:44AM  
07:41AM  
07:30AM  
05:07AM  
Apr-19-21 06:00PM  
09:49AM  
08:30AM  
Apr-15-21 06:59AM  
Apr-14-21 01:47PM  
Apr-13-21 05:50PM  
12:30PM  
08:55AM  
Apr-12-21 09:19AM  
08:00AM  
Apr-10-21 09:00AM  
Apr-09-21 04:06PM  
Apr-08-21 01:38PM  
09:00AM  
07:18AM  
Apr-07-21 09:28AM  
Apr-06-21 09:00AM  
Apr-05-21 01:32PM  
09:47AM  
09:22AM  
Apr-01-21 09:42AM  
08:55AM  
07:32AM  
Mar-31-21 11:18PM  
11:06PM  
Mar-30-21 06:40AM  
Mar-29-21 11:30AM  
10:30AM  
Mar-28-21 06:15AM  
Mar-26-21 12:17PM  
09:24AM  
08:16AM  
06:08AM  
04:00AM  
Mar-25-21 09:10AM  
09:06AM  
08:47AM  
07:43AM  
Mar-24-21 11:06AM  
09:31AM  
08:19AM  
Mar-23-21 02:38PM  
01:27PM  
08:56AM  
Mar-22-21 04:05AM  
Mar-21-21 10:01AM  
Mar-19-21 07:19AM  
06:00AM  
Mar-18-21 03:07PM  
01:15PM  
10:40AM  
Mar-17-21 05:50PM  
01:56PM  
09:36AM  
Mar-16-21 01:42PM  
12:20PM  
07:00AM  
Mar-15-21 12:48PM  
12:46PM  
Mar-12-21 11:30AM  
Mar-11-21 05:45PM  
09:00AM  
Mar-09-21 11:27AM  
09:16AM  
Mar-08-21 09:22AM  
09:00AM  
05:51AM  
04:04AM  
Mar-06-21 01:15AM  
Mar-05-21 05:45PM  
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watkin JaredSENIOR VICE PRESIDENTApr 30Option Exercise56.8385,0434,832,629144,826May 04 07:07 PM
Watkin JaredSENIOR VICE PRESIDENTApr 30Sale119.9094,57611,339,73959,783May 04 07:07 PM
Karam SammySENIOR VICE PRESIDENTApr 27Option Exercise75.908,600652,74031,526Apr 29 06:42 PM
BIRD ROGERSENIOR VICE PRESIDENTApr 27Sale122.009,4391,151,55851,083Apr 29 06:38 PM
Karam SammySENIOR VICE PRESIDENTApr 27Sale122.008,6001,049,20022,926Apr 29 06:42 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMar 03Sale121.796,200755,09851,550Mar 05 07:11 PM
Ginascol John FEXECUTIVE VICE PRESIDENTMar 01Sale120.6135242,45599,321Mar 02 07:30 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01Sale120.61943113,73582,375Mar 02 07:16 PM
DALE MICHAEL DSENIOR VICE PRESIDENTMar 01Sale120.611,475177,90039,691Mar 02 07:13 PM
BRYNELSEN CHARLESSENIOR VICE PRESIDENTMar 01Sale120.611,002120,85143,550Mar 02 07:02 PM
BIRD ROGERSENIOR VICE PRESIDENTMar 01Sale120.611,113134,23960,522Mar 02 06:55 PM
Ahlberg Gregory ASENIOR VICE PRESIDENTMar 01Sale120.611,052126,88214,045Mar 02 06:49 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTMar 01Sale120.611,034124,71150,461Mar 02 08:11 PM
Watkin JaredSENIOR VICE PRESIDENTMar 01Sale120.611,391167,76969,316Mar 02 08:01 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMar 01Sale120.6158770,79857,750Mar 02 07:59 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01Sale120.611,664200,695107,430Mar 02 07:54 PM
Kumbier MichelleDirectorFeb 23Buy122.502,040249,9007,296Feb 25 06:05 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTFeb 22Sale121.8340048,73475,706Feb 23 07:05 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTFeb 16Sale128.4950564,88763,373Feb 18 05:57 PM
Funck Robert EEXECUTIVE VICE PRESIDENTFeb 02Option Exercise39.1231,3251,225,434193,542Feb 04 06:56 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 02Sale123.033,130385,08459,681Feb 03 07:20 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTFeb 01Option Exercise38.78203,3937,887,902355,289Feb 03 07:10 PM
Scoggins Christopher JSENIOR VICE PRESIDENTFeb 01Option Exercise44.8345,0002,017,20084,706Feb 03 07:14 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 01Option Exercise38.4018,750720,00081,561Feb 03 07:20 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 01Sale122.7918,7502,302,26462,811Feb 03 07:20 PM
Scoggins Christopher JSENIOR VICE PRESIDENTFeb 01Sale123.2445,0005,545,80039,706Feb 03 07:14 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTFeb 01Sale123.47203,39325,113,252151,896Feb 03 07:10 PM
NOVAKOVIC PHEBE NDirectorDec 04Option Exercise34.9714,681513,43145,794Dec 08 05:58 PM
NOVAKOVIC PHEBE NDirectorDec 04Sale107.284,790513,84941,004Dec 08 05:58 PM
OSBORN WILLIAM ADirectorNov 24Option Exercise43.6421,448935,99179,745Nov 25 05:41 PM
Funck Robert EExecutive Vice President & CFOOct 26Option Exercise38.4083,3333,199,987265,550Oct 28 06:33 PM
Funck Robert EExecutive Vice President & CFOOct 26Sale108.8383,3339,068,955182,217Oct 28 06:33 PM
Wainer Andrea FExecutive Vice PresidentSep 30Option Exercise38.4030,0001,152,00074,080Oct 01 05:50 PM
Wainer Andrea FExecutive Vice PresidentSep 30Sale107.0130,0003,210,36044,080Oct 01 05:50 PM
Wainer Andrea FExecutive Vice PresidentSep 23Sale102.473,650374,03144,080Sep 25 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentSep 11Sale105.282,500263,20046,267Sep 15 06:14 PM
Ginascol John FExecutive Vice PresidentSep 01Option Exercise43.1672,0983,111,584136,775Sep 03 06:33 PM
BIRD ROGERSenior Vice PresidentSep 01Sale108.736,290683,92956,630Sep 03 05:52 PM
CAPEK JOHN MExecutive Vice PresidentAug 27Option Exercise27.0352,3001,413,857369,100Aug 31 06:27 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentAug 27Option Exercise47.0042,4791,996,513144,912Aug 31 06:28 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentAug 27Sale111.8642,4794,751,701102,433Aug 31 06:28 PM
CAPEK JOHN MExecutive Vice PresidentAug 27Sale111.8652,3005,850,278316,800Aug 31 06:27 PM
NOVAKOVIC PHEBE NDirectorJul 23Option Exercise25.053,73993,67732,046Jul 27 05:06 PM
NOVAKOVIC PHEBE NDirectorJul 23Sale100.7893394,02631,113Jul 27 05:06 PM
AUSTIN ROXANNE SDirectorJul 22Sale99.806,844683,03840,043Jul 23 05:07 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 21Option Exercise0.0023,008096,899Jul 23 05:04 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 21Sale98.0023,0082,254,78473,891Jul 23 05:04 PM
Earnhardt Lisa DExecutive Vice PresidentJun 10Sale90.8487279,21672,074Jun 12 05:07 PM